Classworx
20.7.2021 18:41:42 CEST | ACCESS Newswire | Press release
ATLANTA, GA / ACCESSWIRE / July 20, 2021 / Classworx™, Inc. formerly known as Chill N Out Cryotherapy Inc. (OTC PINK:CHNO) a Virtual Directory for instructors, performers and hosts of virtual classes and events on Zoom, invites Yoga Studios and Instructors who provide Live Zoom Classes to create a profile on Classworx and receive marketing and advertising about your upcoming zoom classes through Classworx.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.While many businesses have experienced lockdowns in the past year and with the upcoming possibility of certain protocols going back into place again, Classworx™ is offering all of its members, whether new or existing, marketing of their upcoming live zoom classes that they list in the ClassWorx directory.
Yoga studios and fitness studios can both join Classworx™ and link their zoom account and stripe merchant account to their Classworx account. Each studio can add the instructors that work for them and set up their individual profiles including their live zoom schedule. Studios that are offering both in person classes along with live zoom classes can list those classes along with the instructor in the Classworx Directory. Classworx will promote through online marketing and advertising your studio along with the instructor that's teaching the classes and the date and time of the classes.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Classworx™ also provides individual instructors the opportunity to create their Classworx profile and list their live zoom events and link their individual zoom and stripe account so that they can receive payments directly as well as studio owners.
The Classworx™ dashboard allows for the studio owners to create their instructor pages with pictures, an about section, the language they teach in, their complete live zoom schedule, videos, and the location from where they're teaching from. The proceeds from each class goes into the studios stripe account if the instructors are registered with a studio, individual instructors receive their payments directly to their Stripe account as well.
Studios and individuals have the option of how they want to offer classes to their attendees. They can either offer a single drop in price, they can offer a block of classes at a discount if they choose to, or they can offer a subscription base which is typically a set price per month and usually provides access to an unlimited amount of classes.
Classworx is looking to work with studio owners and individual instructors to help them promote their brand as well as their class schedule and the classes that they teach.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Classworx understands that the past year has been very exhausting for some studios, with many having gone completely out of business. We want to assist studios that are offering in person classes by assisting them in reaching new people that may not be local to the community or may in fact be local but haven't yet heard of them that now can attend the classes from wherever they are via zoom.
Classworx™ is providing studio owners and instructors a central directory that will pull people in from around the world that can discover your studio, your instructors and the types of classes you teach.
Once you set up your Classworx listing and you've posted your upcoming live zoom schedule, please email peter@classworx.com with a link to your profile on Classworx and we will see that our marketing team begins the advertising and marketing campaign to highlight your profile and your upcoming classes.
About Classworx, Inc. (formerly known as Chill N Out Cryotherapy, Inc.)
Chill N Out Cryotherapy, Inc. (OTC PINK:CHNO), a Delaware Corporation, owns and operates ClassWorx.com. Chill N Out Cryotherapy, Inc. currently trades on the OTC Pinks under the stock symbol CHNO. Classworx provides an internet-based, global network-directory of people offering Virtual classes or events utilizing video conferencing to remotely deliver individual or group instruction in a broad range of disciplines ('virtual classes'). The Company is based in the Atlanta, Georgia, area spans a global outreach through the worldwide web.
Safe Harbor:
This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the 'Exchange Act'), including statements regarding potential sales, the success of the company's business, as well as statements that include the word believe or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements of Chill N Out Cryotherapy, Inc. DBA Classworx to differ materially from those implied or expressed.
Contact:
Raymond Firth
470-448-4734
www.classworx.com
SOURCE: Classworx
View source version on accesswire.com:
https://www.accesswire.com/656298/Classworx-Will-Promote-Your-Live-Zoom-Yoga-Class-Schedule-When-You-Host-Your-Classes-on-ClassWorx
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
GoodData Kicks Off 2026 with MCP Server Launch and Major Enterprise Wins15.4.2026 12:00:00 CEST | Press release
Financial services wins and three platform launches signal accelerating enterprise demand for agentic analytics. SAN FRANCISCO, CA / ACCESS Newswire / April 15, 2026 / GoodData, a leading AI-native decision intelligence platform, today announced strong Q1 2026 results driven by the launch of its MCP Server for agentic analytics, significant new contracts in global financial services, and continued expansion into new markets. The quarter built on a record-breaking 2025, reinforcing GoodData's position as the platform enterprises trust to move AI from pilot to production. Continued growth across enterprise and financial services GoodData's commercial momentum remained strong throughout Q1, with notable wins across the enterprise and financial sectors. The company secured a new three-year contract with one of the world's largest asset managers, and a key long-term customer in global payments renewed for three years while expanding its enterprise license. "Our Q1 results demonstrate that t
GoodData Kicks Off 2026 with MCP Server Launch and Major Enterprise Wins15.4.2026 12:00:00 CEST | Press release
Financial services wins and three platform launches signal accelerating enterprise demand for agentic analytics. SAN FRANCISCO, CA / ACCESS Newswire / April 15, 2026 / GoodData, a leading AI-native decision intelligence platform, today announced strong Q1 2026 results driven by the launch of its MCP Server for agentic analytics, significant new contracts in global financial services, and continued expansion into new markets. The quarter built on a record-breaking 2025, reinforcing GoodData's position as the platform enterprises trust to move AI from pilot to production. Continued growth across enterprise and financial services GoodData's commercial momentum remained strong throughout Q1, with notable wins across the enterprise and financial sectors. The company secured a new three-year contract with one of the world's largest asset managers, and a key long-term customer in global payments renewed for three years while expanding its enterprise license. "Our Q1 results demonstrate that t
OBI Pharma Announces Ten Poster Presentations at the AACR 2026 Annual Meeting for GlycOBI(R) Glycan-based Site-Specific Antibody-Drug Conjugates (ADCs): Mono and Bi-Specific (inc. Dual payload) and Obrion(TM) ADC enabling technologies15.4.2026 10:40:00 CEST | Press release
Poster Presentations featuring the latest advancements on anti-TROP2 (OBI 902) and Nectin-4 (OBI 904) ADCs, anti-TROP2/HER2 BsADC (OBI 201), anti-cMET/HER3Bs-Dual Payload ADC (OBI 221),and OBI's novel Obrion ™ ADC enabling technologies(GlycOBI ® and GlycOBI DUO ®). TAIPEI, TW / ACCESS Newswire / April 15, 2026 / OBI Pharma, Inc. (TPEx:4174.TWO) today announced its presence at AACR 2026, highlighted by ten poster presentations, showcasing the transformative potential of the GlycOBI® platform. Conventional ADCs often face limitations due to random conjugation, resulting in heterogeneous Drug-to-Antibody Ratios (DAR), suboptimal stability, and narrow therapeutic windows. In contrast, the OBI site-specific glycan-based technology enables a highly homogeneous DAR, translating into improved PK/PD profiles, and reduced off-target toxicity, as demonstrated by OBI's lead programs, OBI-902 and OBI-904. We are further advancing precision oncology through our next-generation bispecific (OBI-201) a
OBI Pharma Announces Ten Poster Presentations at the AACR 2026 Annual Meeting for GlycOBI(R) Glycan-based Site-Specific Antibody-Drug Conjugates (ADCs): Mono and Bi-Specific (inc. Dual payload) and Obrion(TM) ADC enabling technologies15.4.2026 10:40:00 CEST | Press release
Poster Presentations featuring the latest advancements on anti-TROP2 (OBI 902) and Nectin-4 (OBI 904) ADCs, anti-TROP2/HER2 BsADC (OBI 201), anti-cMET/HER3Bs-Dual Payload ADC (OBI 221),and OBI's novel Obrion ™ ADC enabling technologies(GlycOBI ® and GlycOBI DUO ®). TAIPEI, TW / ACCESS Newswire / April 15, 2026 / OBI Pharma, Inc. (TPEx:4174.TWO) today announced its presence at AACR 2026, highlighted by ten poster presentations, showcasing the transformative potential of the GlycOBI® platform. Conventional ADCs often face limitations due to random conjugation, resulting in heterogeneous Drug-to-Antibody Ratios (DAR), suboptimal stability, and narrow therapeutic windows. In contrast, the OBI site-specific glycan-based technology enables a highly homogeneous DAR, translating into improved PK/PD profiles, and reduced off-target toxicity, as demonstrated by OBI's lead programs, OBI-902 and OBI-904. We are further advancing precision oncology through our next-generation bispecific (OBI-201) a
IDC Defines the Next Era of Technology Intelligence with the Introduction of IDC Quanta(TM) at Directions 20268.4.2026 17:15:00 CEST | Press release
New AI-powered platform establishes an embedded intelligence layer for the AI economy, delivering decision-grade insight BOSTON, MA / ACCESS Newswire / April 8, 2026 / IDC today opened IDC Directions 2026, its flagship client event, bringing together technology leaders, analysts, and industry experts to examine the forces reshaping the global technology market and to introduce a major evolution in how technology intelligence is delivered. At the center of this year's event is IDC Quanta™, a new AI-powered platform that establishes what IDC defines as the technology intelligence layer for the AI economy. As artificial intelligence accelerates the pace of business and compresses decision cycles, IDC is redefining its role from a destination for research and data to an embedded intelligence capability that delivers trusted insight directly into the workflows where decisions are made. "AI is compressing time across the entire technology market, and that breaks the traditional research mode
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
